gabexate has been researched along with leucine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fantini, L; Morselli-Labate, AM; Pezzilli, R | 1 |
Clavien, PA; Heinrich, S; Rousson, V; Schäfer, M | 1 |
Drosten, C; Erichsen, S; Herrler, G; Herrler, T; Hoffmann, M; Kleine-Weber, H; Krüger, N; Müller, MA; Nitsche, A; Pöhlmann, S; Schiergens, TS; Schroeder, S; Wu, NH | 1 |
1 review(s) available for gabexate and leucine
Article | Year |
---|---|
Evidence-based treatment of acute pancreatitis: a look at established paradigms.
Topics: Acute Disease; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aprotinin; Cholecystectomy; Enteral Nutrition; Evidence-Based Medicine; Gabexate; Gastrointestinal Agents; Humans; Imidazoles; Imipenem; Leucine; Meropenem; Octreotide; Pancreatitis; Pancreatitis, Acute Necrotizing; Platelet Activating Factor; Randomized Controlled Trials as Topic; Serine Proteinase Inhibitors; Sphincterotomy, Endoscopic; Thienamycins | 2006 |
2 other study(ies) available for gabexate and leucine
Article | Year |
---|---|
New approaches for the treatment of acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Antibodies, Monoclonal; Cholangiopancreatography, Endoscopic Retrograde; Clinical Trials as Topic; Drug Evaluation, Preclinical; Gabexate; Humans; Imidazoles; Infliximab; Interleukin-10; Leucine; Nutrition Therapy; Pain; Pancreatitis; Pancreatitis, Acute Necrotizing; Practice Guidelines as Topic; Probiotics; Treatment Outcome | 2006 |
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Topics: Ammonium Chloride; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; Betacoronavirus; Cell Line; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Development; Esters; Gabexate; Guanidines; Humans; Immunization, Passive; Leucine; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Vesiculovirus; Virus Internalization | 2020 |